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Abstract 
People with an inherited condition who receive palliative care may be missing out on the 
opportunity to store a DNA sample for future use by their families and offspring. A DNA 
sample from a family member affected with an inherited condition can help at-risk relatives 
to access accurate risk assessment and, where relevant, enhanced surveillance and risk 
reducing measures. As genetic and genomic testing becomes increasingly important in all 
aspects of health care, health professionals specializing in palliative care will be asked to 
communicate about family history risk and testing. This article highlights the importance of 
discussing genetics and genomics issues for people receiving palliative care, their families 
and the health professionals caring for them. 
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For the person dying from an inherited condition, palliative care may be the last opportunity 
to store a DNA sample for future use by their families and offspring so that they can 
accurately appraise their individual risk of developing the same condition. Banking a DNA 
sample for future use may enable family members to access an accurate risk assessment 
and make informed decisions about managing their own risk and the risk to their children, for 
example, engaging in appropriate screening or risk reducing surgery. Yet, despite the global 
recognition of the importance of genetics and genomics in healthcare, discussion of these 
issues is largely missing from the palliative care agenda (Morrow et al., 2018). 
 
A large proportion of people receiving palliative care will have a diagnosis of cancer. Up to 
10% of common cancers are due to a pathogenic variant (gene mutation) (Foulkes, 2008). 
Most inherited common cancers, such as breast and ovarian cancer and Lynch Syndrome 
are dominantly inherited, whereby each first-degree relative (child, sibling or parent) of an 
affected individual is at 50% risk of having inherited the pathogenic variant. In addition to 
cancer, there are other adult onset life-limiting conditions that are, or can be, due to a 
pathogenic variant, such as Huntington’s disease, adult-onset autosomal dominant 
leukodystrophy and Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and 
Leukoencephalopathy (CADASIL). For children receiving palliative care, there is an even 
higher possibility of genetic involvement with up to 50% of expected childhood deaths being 
due to a pathogenic variant (Burton, 2003). 
 
There is growing awareness of the importance of identifying individuals with inherited 
conditions early in their diagnosis, especially in the management of cancer where targeted 
treatment may be available. Genomic testing is increasingly relevant to all areas of 
medicine, with governments from over 14 countries, including the UK, Australia, the USA 
and parts of Europe, making substantial investments in the translation of genomic research 
into mainstream clinical practice (Stark et al, 2019).  
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There are several reasons why families may be unaware of the possibility of an inherited 
condition close to the end of life. Older people and those diagnosed at a late stage of 
disease may be referred directly into palliative care, bypassing medical oncology. Family 
histories are dynamic and sometimes genetic testing may not be offered until several 
relatives have been diagnosed with a similar condition. Alternatively, people may have been 
offered testing at an earlier stage and declined, but change their minds as the focus of 
testing shifts from the individual to the family.  
 
People who are eligible for genetic testing are frequently not identified from palliative care 
(Daniels et al., 2009, Quillin et al., 2010). Even when eligible individuals are identified, they 
are not always referred to specialist genetics services (Lanceley et al., 2012). There are 
many possible barriers to discussing genetic testing in palliative care, including lack of 
confidence and knowledge (Quillin et al., 2011), limited awareness of how to access 
genetics services (Metcalfe et al., 2009, Metcalfe et al., 2010, Dearing and Taverner, 2017), 
uncertainty about whose responsibility it is to raise the issue with eligible individuals and 
families (Metcalfe et al., 2009, Metcalfe et al., 2010) and concern about causing additional 
distress (Lillie et al., 2011).  Yet, people receiving palliative care have expressed positive 
feelings about discussing genetic testing, such as reassurance, interest and a sense of 
altrusim (Abusamaan et al., 2018, Daniels et al., 2009, Lillie et al., 2011). Overcoming these 
barriers requires an in depth understanding of the attittudes, behaviours and knowledge of 
palliative care health professionals towards genetic testing and a evidence-based approach 
to changing practice.  
 
Unless the issue is raised with individuals and families in the palliative care setting, those not 
at high risk may be concerned where they could be reassured. Alternatively, those at high 
risk may miss out on the opportunity to help their loved ones understand the cause of the 
condition, protect future generations and enable targeted treatment of relatives who may 
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all aspects of health care, health professionals in all areas, including palliative care, will be 
asked to communicate about family history risk and testing.  
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